𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clozapine for medication-related pathological gambling in Parkinson disease

✍ Scribed by Alessandro Rotondo; Domenico Bosco; Massimiliano Plastino; Arturo Consoli; Francesca Bosco


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
290 KB
Volume
25
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Internet gambling and other pathological
✍ Sui H. Wong; Zenita Cowen; Elizabeth Anne Allen; Peter K. Newman πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 51 KB

This case series, as well as a subsequent prospective survey of 100 PD patients, was presented as a poster at the Association of British Neurologists autumn meeting, October 2006 in London.

Prevalence of pathological gambling in p
✍ Maurizio Avanzi; Mario Baratti; Silvia Cabrini; Elena Uber; Gianni Brighetti; Fl πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 58 KB

## Abstract Pathological gambling (PG) is a psychiatric disorder characterized by loss of control of gambling, which has repercussions on family, personal, and professional life. Several recent studies have reported the relationship between PG and the treatment of Parkinson's disease (PD), but no p

Cognitive dysfunctions and pathological
✍ Gabriella Santangelo; Carmine Vitale; Luigi Trojano; Francesca Verde; Dario Gros πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 81 KB

## Abstract The purpose of this study was to investigate the neuropsychological correlates of pathological gambling (PG) in Parkinson's disease (PD). Fifteen patients with PD affected by PG (identified based on DSM‐IV criteria; PD+PG) without clinically evident dementia were compared with 15 nondem

Clozapine for psychosis in Parkinson's d
✍ Dr. Ronald F. Pfeiffer; Jasbir Kang; Benjamin Graber; Ruth Hofman; James Wilson πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 321 KB πŸ‘ 1 views

## Abstract The clinical efficacy of clozapine, an atypical antipsychotic, in treating levodopa‐induced hallucinations was investigated in five patients with Parkinson's disease under open label conditions. Two patients could not tolerate clozapine, even in doses as low as 12.5–25 mg daily, because